Journal of Internal Medicine Concepts & Practice >
All-trans retinoic acid promotes apoptosis effect of tumor necrosis factor related apoptosis induced ligand on a variety of pancreatic cancer cells
Received date: 2023-03-21
Online published: 2023-08-07
Objective To observe whether all trans retinoic acid (ATRA) can promote the apoptosis effect of tumor necrosis factor related apoptosis induced ligand (TRAIL) on various pancreatic cancer cells. Methods The pCA13 plasmid carrying TRAIL gene was transfected into three types of pancreatic cancer cell SW1990, Patu8988 and Bx-PC3 respectively. ATRA or equivalent solvent was added after 24 h of transfection. The cell viability was measured by the methyl thiazolyl tetrazolium(MTT) method, apoptosis rates and the expression of TRAIL receptor R1 and R2 were detected by flow cytometry, and the apoptosis was observed by terminal deoxynucleotidyl transferase(TdT) mediated dUTP nick end labeling (TUNEL) and Hoechst double staining and transmission electron microscopy. Results The cell viability of the TRAIL+ATRA group was significantly inhibited compared to the group without ATRA (P<0.05). The result of the flow cytometry showed that ATRA significantly promoted cell apoptosis compared with the group without ATRA(P<0.05). Apoptosis was observed by transmission electron microscopy after TUNEL and Hoechst double staining. However, there was no significant difference in expression of TRAIL-R1 and R2 between the TRAIL+ATRA group and the non-ATRA group(P>0.05). Conclusions ATRA can promote the apoptosis of TRAIL on various pancreatic cancer cells, and its mechanism is not related to the up-regulation of TRAIL-R1 and R2.
ZHU Ying, TANG Yuming, HUANG Jia, ZHANG Yongping, YAO Weiyan . All-trans retinoic acid promotes apoptosis effect of tumor necrosis factor related apoptosis induced ligand on a variety of pancreatic cancer cells[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(03) : 171 -176 . DOI: 10.16138/j.1673-6087.2023.03.007
[1] | 朱颖, 汤玉茗, 黄佳, 等. 肿瘤坏死因子相关凋亡诱导配体对胰腺癌细胞凋亡的影响[J]. 中华胰腺病杂志, 2019, 19(3): 198-201. |
[2] | Kretz AL, von Karstedt S, Hillenbrand A, et al. Should we keep walking along the trail for pancreatic cancer treatment?[J]. Cancers (Basel), 2018, 10(3): 77. |
[3] | Farooqi AA, Zahid R, Maryam A, et al. TRAIL mediated signaling as a double-edged sword in pancreatic cancer[J]. Cell Mol Biol (Noisy-le-grand), 2020, 66(3): 215-220. |
[4] | Kim JH, Kim MJ, Choi KC, et al. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover[J]. Int J Biochem Cell Biol, 2016, 78:327-334. |
[5] | Hu Y, Li R, Jin J, et al. Quercetin improves pancreatic cancer chemo-sensitivity by regulating oxidative-inflammatory networks[J]. J Food Biochem, 2022, 46(12): e14453. |
[6] | Huang M, Zhu H, Yi C, et al. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer[J]. Cancer Chemother Pharmacol, 2018, 82(5): 829-838. |
[7] | Ben Khaled N, Hammer K, Ye L, et al. TRAIL receptor targeting agents potentiate PARP inhibitor efficacy in pancreatic cancer independently of BRCA2 mutation status[J]. Cancers (Basel), 2022, 14(21): 5240. |
[8] | Huang X, Ou C, Shu Y, et al. A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endogenous apoptotic pathway[J]. Biomaterials, 2021, 272:120795. |
[9] | Hu W, Jia X, Gao Y, et al. Chaetospirolactone reverses the apoptotic resistance towards TRAIL in pancreatic cancer[J]. Biochem Biophys Res Commun, 2018, 495(1): 621-628. |
[10] | Dai H, Jiang Y, Luo Y, et al. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1[J]. Phytomedicine, 2019, 62: 152953. |
/
〈 |
|
〉 |